![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Seidman Michael
Publisher: Springer Publishing Company
ISSN: 0920-3206
Source: Cardiovascular Drugs and Therapy, Vol.28, Iss.2, 2014-04, pp. : 111-112
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wang Hao Zhang Zhixiang Tian Weijun Liu Tong Han Hongqiu Garcia Bertha Li Xian Du Caigan
Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Wang Hao Zhang Zhixiang Tian Weijun Liu Tong Han Hongqiu Garcia Bertha Li Xian Du Caigan
Cardiovascular Drugs and Therapy, Vol. 28, Iss. 2, 2014-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Everolimus suppresses cardiac-allograft vasculopathy
Inpharma, Vol. 1, Iss. 1403, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)